Atorvastatin limits the pro-inflammatory response of rat aortic smooth muscle cells to thrombin
- 29 July 2003
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 474 (2-3) , 175-184
- https://doi.org/10.1016/s0014-2999(03)02043-0
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Pharmacodynamics and Pharmacokinetic-Pharmacodynamic Relationships of Atorvastatin, an HMG-CoA Reductase InhibitorThe Journal of Clinical Pharmacology, 2000
- Recent advances torwards understanding redox mechanisms in the activation of nuclear factor κbFree Radical Biology & Medicine, 2000
- The Role of Rho in G Protein-Coupled Receptor Signal TransductionAnnual Review of Pharmacology and Toxicology, 2000
- Atorvastatin reduces NF-κB activation and chemokine expression in vascular smooth muscle cells and mononuclear cellsAtherosclerosis, 1999
- Relaxant and Contractile Responses of Porcine Pulmonary Arteries to Thrombin and Thrombin Receptor Activating PeptidesSeminars in Thrombosis and Hemostasis, 1996
- The biology of HMG-CoA reductase: the pros of contra-regulationTrends in Biochemical Sciences, 1996
- Thrombin hypothesis of thrombus generation and vascular lesion formationThe American Journal of Cardiology, 1995
- Interleukin 6 gene transcripts are expressed in human atherosclerotic lesionsCytokine, 1994
- Elevated plasma interleukin-6 levels in patients with acute myocardial infarctionAmerican Heart Journal, 1993
- A Receptor-Mediated Pathway for Cholesterol HomeostasisScience, 1986